Single-center experience of 60 consecutive simultaneous pancreas-kidney transplants using mycophenolate mofetil and tacrolimus as primary maintenance immunotherapy

Transplant Proc. 1999 Feb-Mar;31(1-2):615-6. doi: 10.1016/s0041-1345(98)01581-4.
No abstract available

Publication types

  • Clinical Trial

MeSH terms

  • Actuarial Analysis
  • Antilymphocyte Serum / therapeutic use
  • Drug Therapy, Combination
  • Follow-Up Studies
  • Graft Rejection / drug therapy
  • Graft Rejection / pathology
  • Graft Survival
  • Humans
  • Immunosuppressive Agents / therapeutic use*
  • Kidney Transplantation / immunology*
  • Kidney Transplantation / methods
  • Kidney Transplantation / mortality
  • Muromonab-CD3 / therapeutic use
  • Mycophenolic Acid / analogs & derivatives*
  • Mycophenolic Acid / therapeutic use
  • Pancreas Transplantation / immunology*
  • Pancreas Transplantation / methods
  • Pancreas Transplantation / mortality
  • Postoperative Complications
  • Survival Analysis
  • Tacrolimus / therapeutic use*
  • Time Factors

Substances

  • Antilymphocyte Serum
  • Immunosuppressive Agents
  • Muromonab-CD3
  • Mycophenolic Acid
  • Tacrolimus